| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.6B | $3.0B | $3.2B | $2.8B | $2.1B | $1.8B | $0.6B | $0.7B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.3B | $0.2B | $0.3B | $0.3B | $0.1B | $-0.2B | $0.1B | $0.0B |
| Net Income | $-0.4B | $-0.1B | $0.1B | $0.1B | $-0.2B | $-0.4B | $0.0B | $-0.0B |
| EPS (Basic) | $-4.19 | $-1.24 | $0.22 | $-0.04 | $-1.96 | — | — | — |
| EPS (Diluted) | $-4.19 | $-1.24 | $0.22 | $-0.04 | $-1.96 | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $4.9B | $7.0B | $7.0B | $6.4B | $5.9B | $5.9B | $6.6B | $6.5B |
| Current Assets | $0.7B | $0.9B | $1.0B | $0.9B | $0.5B | $0.6B | $0.6B | $0.4B |
| Cash & Equivalents | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Total Liabilities | $4.2B | $5.5B | $5.3B | $4.6B | $3.9B | $4.2B | $4.3B | $4.0B |
| Current Liabilities | $0.7B | $0.9B | $1.0B | $0.7B | $0.5B | $0.4B | $0.4B | $0.3B |
| Stockholders' Equity | — | — | — | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.3B | $0.4B | $0.5B | $0.3B | $0.3B | $0.3B | $0.4B | $0.4B |
| Investing Cash Flow | $0.8B | $-0.6B | $-0.6B | $-0.4B | $-0.3B | $-0.1B | $-0.1B | $0.1B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-1.1B | $0.2B | $0.1B | $0.0B | $-0.1B | $-0.2B | $-0.2B | $-0.5B |